Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Undifferentiated Pleomorphic Sarcoma”

45 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 45 results

Early research (Phase 1)Looking for participantsNCT05607095
What this trial is testing

LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, or Dedifferentiated Liposarcoma

Who this might be right for
Uveal MelanomaMelanomaMetastatic Uveal Melanoma+1 more
Memorial Sloan Kettering Cancer Center 30
Large-scale testing (Phase 3)Study completedNCT02451943
What this trial is testing

Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma
Eli Lilly and Company 509
Testing effectiveness (Phase 2)Study completedNCT01154452
What this trial is testing

Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma

Who this might be right for
Adult Alveolar Soft Part SarcomaAdult AngiosarcomaAdult Desmoplastic Small Round Cell Tumor+32 more
National Cancer Institute (NCI) 78
Testing effectiveness (Phase 2)Study completedNCT00400569
What this trial is testing

Phase II Study of Sunitinib Malate for Metastatic and/or Surgically Unresectable Soft Tissue Sarcoma

Who this might be right for
LiposarcomaLeiomyosarcomaFibrosarcoma+1 more
H. Lee Moffitt Cancer Center and Research Institute 48
Testing effectiveness (Phase 2)Study completedNCT00031915
What this trial is testing

Imatinib Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma or Bone Sarcoma

Who this might be right for
Childhood Malignant Fibrous Histiocytoma of BoneSarcoma
National Cancer Institute (NCI)
Large-scale testing (Phase 3)Study completedNCT00002764
What this trial is testing

Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma

Who this might be right for
Endometrial CancerKidney CancerMetastatic Cancer+3 more
European Organisation for Research and Treatment of Cancer - EORTC 340
Testing effectiveness (Phase 2)Study completedNCT01653028
What this trial is testing

Alisertib in Treating Patients With Advanced or Metastatic Sarcoma

Who this might be right for
MyxofibrosarcomaRecurrent Adult Soft Tissue SarcomaRecurrent Leiomyosarcoma+5 more
National Cancer Institute (NCI) 72
Testing effectiveness (Phase 2)Study completedNCT02584309
What this trial is testing

Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma

Who this might be right for
Sarcoma, Soft TissueSoft Tissue SarcomaUndifferentiated Pleomorphic Sarcoma+8 more
Washington University School of Medicine 73
Early research (Phase 1)Study completedNCT00720174
What this trial is testing

Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma

Who this might be right for
Adult AngiosarcomaAdult Desmoplastic Small Round Cell TumorAdult Epithelioid Sarcoma+32 more
National Cancer Institute (NCI) 30
Early research (Phase 1)Study completedNCT00030784
What this trial is testing

Liposomal Doxorubicin Plus Ifosfamide in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma

Who this might be right for
Sarcoma
European Organisation for Research and Treatment of Cancer - EORTC 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT05836571
What this trial is testing

Testing Ipilimumab and Nivolumab Combination With or Without Cabozantinib in People >= 18 Years Old With Advanced Soft Tissue Sarcoma

Who this might be right for
Locally Advanced Extraskeletal Myxoid ChondrosarcomaLocally Advanced LeiomyosarcomaLocally Advanced Liposarcoma+7 more
National Cancer Institute LAO 66
Large-scale testing (Phase 3)Ended earlyNCT01189253
What this trial is testing

Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma

Who this might be right for
Sarcoma
European Organisation for Research and Treatment of Cancer - EORTC 133
Testing effectiveness (Phase 2)WithdrawnNCT04906876
What this trial is testing

9-ING-41Combined With Chemotherapy in Adolescents and Adults With Advanced Sarcomas

Who this might be right for
SarcomaSoft Tissue SarcomaMetastatic Sarcoma+10 more
Brown University
Testing effectiveness (Phase 2)Ended earlyNCT05017103
What this trial is testing

Sintilimab for the Treatment of Locally Advanced, Metastatic, Recurrent, or Unresectable Undifferentiated Pleomorphic Sarcoma, SiARa Cancer Study

Who this might be right for
Locally Advanced Undifferentiated Pleomorphic SarcomaMetastatic Undifferentiated Pleomorphic SarcomaRecurrent Undifferentiated Pleomorphic Sarcoma+1 more
M.D. Anderson Cancer Center 6
Early research (Phase 1)Study completedNCT04242238
What this trial is testing

Study of DCC-3014 in Combination With Avelumab in Patients With Advanced or Metastatic Sarcomas

Who this might be right for
SarcomaAdvanced SarcomaHigh Grade Sarcoma+4 more
Memorial Sloan Kettering Cancer Center 32
Testing effectiveness (Phase 2)UnknownNCT04356872
What this trial is testing

The Combination of Sintilimab and AI (Doxorubicin, ADM/Ifosfamide, IFO) for the First Line Treatment of Select Type of Metastatic/Unresectable Soft Tissue Sarcoma

Who this might be right for
Sarcoma, Soft Tissue
Fudan University 45
Early research (Phase 1)Study completedNCT00020267
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Cancer

Who this might be right for
Lung CancerAdult Soft Tissue SarcomaColorectal Cancer+8 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00245102
What this trial is testing

Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma

Who this might be right for
Adult AngiosarcomaAdult Epithelioid SarcomaAdult Leiomyosarcoma+12 more
National Cancer Institute (NCI) 147
Testing effectiveness (Phase 2)Study completedNCT02500797
What this trial is testing

Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Sarcoma That Cannot Be Removed by Surgery

Who this might be right for
Locally Advanced Bone SarcomaLocally Advanced Dedifferentiated LiposarcomaLocally Advanced Gastrointestinal Stromal Tumor+18 more
National Cancer Institute (NCI) 164
Not applicableWithdrawnNCT00334984
What this trial is testing

Glutamine in Preventing Oral Mucositis in Patients Receiving Chemotherapy for Sarcoma

Who this might be right for
Childhood Malignant Fibrous Histiocytoma of BoneSarcoma
Children's Oncology Group
Load More Results